In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $13.07 down -1.21% from its previous closing price of $13.23. In other words, the price has decreased by -$1.21 from its previous closing price. On the day, 1.7 million shares were traded. TAK stock price reached its highest trading level at $13.19 during the session, while it also had its lowest trading level at $13.05.
Ratios:
For a deeper understanding of Takeda Pharmaceutical Co ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 20.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.77. For the most recent quarter (mrq), Quick Ratio is recorded 0.55 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 24 ’24 when TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares for $8.10 per share. The transaction valued at 29,999,994 led to the insider holds 3,755,583 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 41412423680 and an Enterprise Value of 4939109629952. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 32.68, and their Forward P/E ratio for the next fiscal year is 28.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1634.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 0.86. Its current Enterprise Value per Revenue stands at 1.185 whereas that against EBITDA is 4.087.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $17.11, while it has fallen to a 52-week low of $13.11. The 50-Day Moving Average of the stock is -7.45%, while the 200-Day Moving Average is calculated to be -10.49%.
Shares Statistics:
For the past three months, TAK has traded an average of 1.82M shares per day and 1639890 over the past ten days. A total of 3.14B shares are outstanding, with a floating share count of 3.14B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.45% stake in the company. Shares short for TAK as of 1713139200 were 5971933 with a Short Ratio of 3.28, compared to 1710460800 on 5501771.
Dividends & Splits
According to the company, the forward annual dividend rate for TAK is 0.32, from 184.0 in the trailing year. Against a Trailing Annual Dividend Yield of 13.907785The stock’s 5-year Average Dividend Yield is 4.72.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
